Standardizing biomarker testing for Canadian patients with advanced lung cancer

BACKGROUND: The development and approval of both targeted and immune therapies for patients with advanced non-small cell lung cancer (nsclc) has significantly improved patient survival rates and quality of life. Biomarker testing for patients newly diagnosed with nsclc, as well as for patients progr...

Full description

Saved in:
Bibliographic Details
Published in:Curr Oncol
Main Authors: Melosky, B., Blais, N., Cheema, P., Couture, C., Juergens, R., Kamel-Reid, S., Tsao, M.-S., Wheatley-Price, P., Xu, Z., Ionescu, D.N.
Format: Artigo
Language:Inglês
Published: Multimed Inc. 2018
Subjects:
Practice Guideline
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5832280/
https://ncbi.nlm.nih.gov/pubmed/29507487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.25.3867
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items